Stuart Ember is a protein chemist with over 10 years of postgraduate experience, currently leading structural biology initiatives at Johnson & Johnson. Previously, they managed early development portfolios and directed teams at Moffitt Cancer Center and Reaction Biology Corporation, contributing significantly to drug discovery efforts, including patented compounds. Stuart began their research career at Imperial College London and The University of Edinburgh, focusing on infectious disease biosensing and viral interactions. Their expertise encompasses structural biology, biophysical assays, and formulation development for diverse biopharmaceuticals.
This person is not in the org chart
This person is not in any teams
This person is not in any offices